NCT04477720

Brief Summary

De-identified deceased HCC patients who were not surgical candidates were evaluated for their clinical baseline characteristics associated with their survival. Baselines included tumor markers, blood counts and liver function tests and CAT-scan based tumor size and numbers and presence of portal vein thrombosis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 1995

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 1995

Completed
13.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
11.2 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 20, 2020

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2020

Enrollment Period

13.9 years

First QC Date

July 16, 2020

Last Update Submit

July 25, 2023

Conditions

Survival

Keywords

HCC, AFP, MTD, survival, NLR, PLR, Tumor Aggressiveness

Outcome Measures

Primary Outcomes (1)

  • Survival

    Overall survival

    10 years

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsYes
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting for HCC management

You may qualify if:

  • biopsy-proven HCC

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Metatropic dwarfism

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2020

First Posted

July 20, 2020

Study Start

June 1, 1995

Primary Completion

May 1, 2009

Study Completion

May 1, 2009

Last Updated

July 27, 2023

Record last verified: 2020-07